Glaxosmithkline (GSK)

 

Latest News

ViiV receives results from NEAT study

ViiV Healthcare, owned by GlaxoSmithKline, has announced positive interim results from the NEAT 02 study of more th...

GSK owned ViiV receives positive results from DAWNING study

ViiV Healthcare, owned by GlaxoSmithKline, has announced positive interim results from the DAWNING study, modifie...

ViiV announces results from NEAT 022 study

RNS Number: 0440M GlaxoSmithKline PLC 25 July 2017 Switching to a dolutegravir regimen from a boosted protease inhibitor regimen maintained viral suppression and improved lipid fractions in patients with HIV and high cardiovascular risk Data presented at the International AIDS Society meeting in Paris London, UK. 25 July 2017 - ViiV Healthcare and NEA...

ViiV announces positive results from DAWNING

RNS Number: 0434M GlaxoSmithKline PLC 25 July 2017 ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings DAWNING study modified to allow patients the opportunity to receive dolutegravir-based regimens London, UK. 25 July 2017 - ViiV Healthcare, the global specialis...

All News

DateHeadlineSource
25-07-17ViiV receives results from NEAT studyStockMarketWire
25-07-17GSK owned ViiV receives positive results from DAWNING studyStockMarketWire
25-07-17ViiV announces results from NEAT 022 studyRNS
25-07-17ViiV announces positive results from DAWNINGRNS
25-07-17Broker Forecast - Bryan Garnier issues a broker note on GlaxoSmithKline PLCStockMarketWire
24-07-17LATTE-2 phII results presented at IAS in ParisRNS
21-07-17Director/PDMR ShareholdingRNS
21-07-17Director/PDMR ShareholdingRNS
21-07-17GSK submits EU filing for extended use of Relvar ElliptaStockMarketWire
21-07-17GSK appoints new non-execStockMarketWire
21-07-17GSK submits EU filing for Relvar Ellipta extensionRNS
21-07-17Directorate ChangeRNS
17-07-17Director/PDMR ShareholdingRNS
17-07-17Director/PDMR ShareholdingRNS
17-07-17Director/PDMR ShareholdingRNS
17-07-17Director/PDMR ShareholdingRNS
17-07-17Director/PDMR ShareholdingRNS
17-07-17Director/PDMR ShareholdingRNS
17-07-17Dividends on course for record in 2017Money Observer
17-07-17Director/PDMR ShareholdingRNS
14-07-17Director/PDMR ShareholdingRNS
14-07-17Director/PDMR ShareholdingRNS
14-07-17Director/PDMR ShareholdingRNS
14-07-17Director/PDMR ShareholdingRNS
12-07-17Director/PDMR ShareholdingRNS
10-07-17The best UK equity funds of 2017Money Observer
05-07-17Strong trading at Persimmon sparks housebuilder rallyStockMarketWire
05-07-17Broker Forecast - Citigroup issues a broker note on GlaxoSmithKline PLCStockMarketWire
03-07-17Total Voting RightsRNS
28-06-17GSK announces US filing for mepo in EGPARNS
27-06-17GSK starts phase III study on mepoStockMarketWire
27-06-17GSK starts phIII study on mepo for nasal polypsRNS
22-06-17Insurers and utilities drag FTSE lowerStockMarketWire
21-06-17Director/PDMR ShareholdingRNS
21-06-17GSK to unveil Zoster-048 clinical study resultsStockMarketWire
21-06-17GSK presents Shingrix PhIII study results at ACIPRNS
20-06-17GSK confirms start date for Luke MielsStockMarketWire
19-06-17GSK confirms start date for Luke MielsRNS
16-06-17The week ahead: Big day for Sirius MineralsInteractive Investor
16-06-17Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLCStockMarketWire

RSS feeds

  • Editorial news feed for LSE:GSK Editorial
  • Regulatory news feed for LSE:GSK Regulatory